Eli Lilly flies to Washington, D.C., the week of drug pricing hearings

Eli Lilly flew from Indianapolis International Airport to Reagan National Airport on June 2, 2026, arriving at 4:47 p.m. local time in a Gulfstream G500, tail N307EL. The 1-hour-27-minute hop put the company’s leadership on the ground in the nation’s capital.

The same week, the Senate Finance Committee is holding hearings on the next round of Medicare drug price negotiations, which include Eli Lilly's blockbuster insulin products and the GLP-1 franchise, per a Reuters report on June 1. The bill, advancing alongside similar legislation in the House, directly affects Lilly’s revenue from Mounjaro and Zepbound—sales that totaled $45 billion last year.

The flight to Washington fits a pattern. Eli Lilly’s G500s have made multiple trips to the D.C. area in recent weeks: on May 22, another Lilly G500 flew from Reagan to Indianapolis, and on May 28, a jet landed at Teterboro, the preferred airport for Manhattan. The company’s Washington visits have tracked with each legislative milestone in the drug-pricing debate, suggesting a coordinated presence near regulators and lawmakers as the calendar moves toward a markup vote.